Cysay Inc.

Company

PC画面背景画像 SP画面背景画像

Greetings

SP代表取締役の画像

Aging control and overcoming intractable diseases are major challenges in an aging society.
Developed countries, including Japan, are facing an aging society with a declining birthrate.
To address the issue of healthy and long life, our company has been conducting research on regenerative medicine that does not use stem cells.
As a company at the forefront of stem cell culture research, we have obtained numerous international patents and have made it possible to mass-produce safe and homogeneous stem cell culture supernatant as a Japan-originated technology.
We meet a wide range of needs from familiar regenerative medicine to keep you healthy and young to advanced regenerative medicine to overcome intractable diseases.

Representative Director Yasuhiro Yamashita

PC代表取締役の画像

Company Profile

Company Name Cysay Inc.
Establishment February, 2012
Representative Director Yasuhiro Yamashita
Business activities Research and development of immortalized cells and cultured supernatants, drug discovery business, sales of food and cosmetic ingredients
Head Quarter 5F, 5-1-5, Toranomon, Minato, Tokyo 105-0001 Japan
Tel +81-(0)3-6411-9013
Capital 118 million yen
Number of employees 15
Board of Directors

Board of Directors

Michiyo Yamashita

Ryo Okada


Director (Outside)

Masatoshi Ishikawa

Masayuki Kimura

Masaki Murata

Munehisa Kaneda


Corporate Auditor

Masashi Kikuchi


Auditor (part-time)

Chihaya Konno

*From December 1, 2024
Attorney at Law

Legal Advisor of

TMI Sogo Law Office

Shinohara Sogo Law Office

Patent Attorney

Patent Attorney Advisor

Ayafune International Patent Firm

History

In 2012
  • Founded
  • Started research under the guidance of Nagoya University.
In 2013
  • Quarrymen&Beauty Inc.
  • Begins test marketing of products containing regenerative factors.
In 2014 Diabetes clinical research begins with South Tohoku Hospital Group
In 2016 Saitama University “Molecular Targeted Capsule” research begins
In 2017 Started joint research with Tokyo Medical University “Stem Cell Culture Protocol” and “Cytokine Analysis
In 2018 Test marketing ends, ODM/OEM orders begin
In 2019 Start of raw material supply
In 2020 Relocation of Cysay Inc. headquarters to Toranomon, Minato-ku, Tokyo
In 2023
  • Exhibiting at CPHI (International Pharmaceutical Development Exhibition)
  • Publication

    Protective effects of conditioned media of immortalized stem cells from human exfoliated deciduous teeth on pressure ulcer formation. Front Immnol. 2023 Jan 13;13:1010700

    https://pubmed.ncbi.nlm.nih.gov/36713359/
In 2024
  • Exhibited at CPHI (International Pharmaceutical Development Exhibition)
  • Exhibited at BWJ Tokyo (Beauty World Japan Tokyo)

Contact

Please feel free to contact us

Contact Us